ECIA heads into the final weeks before its June 18 Q4 earnings with a striking and unusual lending setup: cost to borrow has rocketed more than 900% over the past month, while the stock itself posted a 83% weekly gain on thin OTC volume as of its last recorded close.
The dominant story this week is the dramatic repricing in the borrow market. Cost to borrow has climbed to 15.1% annualised — up 52% from a week ago and a staggering twentyfold rise from the 0.68% level recorded in mid-January. For context, borrowing ECIA was essentially free just three months ago; now it is materially expensive. Borrow availability remains relatively comfortable at roughly 459% of estimated short interest, suggesting the market is not yet stressed for supply. But the speed of the cost increase tells a different story about demand. Short interest itself remains trivial — just 0.1% of the free float, around 17,000 shares — so this is not a heavily shorted stock in any conventional sense. What has changed is the pace: the estimated short position more than tripled in the month of April before pulling back modestly in the most recent readings.
The ORTEX short score is a middling 51.4, down from a brief spike to 55.3 on April 16, around the same time the stock touched a utilisation peak of 100% — meaning every available share in the lending pool was out on loan. That level eased sharply to 61% on April 28, which explains some of the cost-to-borrow stabilisation. Still, the lending market in ECIA has spent most of the past month close to fully utilised: of the 30 daily readings in the dataset, the majority show utilisation above 85%. The borrow pool for this $3.4 million market cap micro-cap is vanishingly small, so even a handful of speculative shorts can swing these metrics dramatically.
The catalyst context matters here. On April 14, Encision published its fiscal 2026 full-year results. The stock was already beginning a sharp re-rating — it rose 83% in the week surrounding the print — and the borrow costs began climbing almost simultaneously. Prior earnings events show the stock is capable of enormous single-session moves: a November 2025 earnings release produced a next-day gain of 55.5%, with the five-day follow-through extending to 51%. An August 2025 event produced a 90% five-day move. These are not anomalies for a company this size; they reflect the stock's extreme illiquidity and the outsized relative impact of any single buyer or seller.
Insider buying from August 2025 — though now eight months stale — is worth noting as structural background. The founder, the CEO (Gregory Trudel), the controller, and a director all bought shares at $0.10 on the same date, collectively acquiring 4.75 million shares for $475,000. The stock has since doubled from those levels to $0.20. None of the reported top holders have filed position changes since that cluster, so the shareholder base appears tightly held and largely static.
With Q4 results expected June 18, the pace of borrow cost changes and any further movement in short position size in the weeks ahead are the metrics worth tracking most closely.
See the live data behind this article on ORTEX.
Open ECIA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
